デフォルト表紙
市場調査レポート
商品コード
1729583

日本の人工臓器およびバイオニックインプラント市場レポート:製品タイプ、技術、地域別、2025年~2033年

Japan Artificial Organs and Bionic Implants Market Report by Product Type (Artificial Organ, Bionics), Technology (Mechanical Bionics, Electronic Bionics), and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 120 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
日本の人工臓器およびバイオニックインプラント市場レポート:製品タイプ、技術、地域別、2025年~2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 120 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の人工臓器およびバイオニックインプラントの市場規模は2024年に24億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに47億米ドルに達し、2025年から2033年にかけて7.6%の成長率(CAGR)を示すと予測しています。臓器不全につながる慢性疾患の増加、外科手術の低コスト化、医療ツーリズムの人気の高まりなどが、市場を牽引する主な要因となっています。

本レポートで扱う主な質問

  • 日本の人工臓器およびバイオニックインプラント市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本の人工臓器およびバイオニックインプラント市場に与えた影響は?
  • 日本の人工臓器およびバイオニックインプラント市場の製品タイプ別区分は?
  • 日本の人工臓器およびバイオニックインプラント市場の技術別区分は?
  • 日本の人工臓器およびバイオニックインプラント市場のバリューチェーンにおける様々なステージとは?
  • 日本の人工臓器およびバイオニックインプラントの主な促進要因と課題は?
  • 日本の人工臓器およびバイオニックインプラント市場の構造と主要プレーヤーは?
  • 日本の人工臓器およびバイオニックインプラント市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の人工臓器およびバイオニックインプラント市場:イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の人工臓器およびバイオニックインプラント市場情勢

  • 過去および現在の市場動向(2019~2024年)
  • 市場予測(2025~2033年)

第6章 日本の人工臓器およびバイオニックインプラント市場:製品タイプ別内訳

  • 人工臓器
  • バイオニクス

第7章 日本の人工臓器およびバイオニックインプラント市場:技術別内訳

  • メカニカルバイオニクス
  • 電子バイオニクス

第8章 日本の人工臓器およびバイオニックインプラント市場:競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本の人工臓器およびバイオニックインプラント市場:業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第11章 付録

目次
Product Code: SR112025A12984

The Japan artificial organs and bionic implants market size reached USD 2.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.6% during 2025-2033. The rising number of chronic diseases that lead to organ failures, the low cost of surgical procedures, and the growing popularity of medical tourism represent some of the key factors driving the market.

Artificial organs and bionic implants are advanced innovations in the field of medicine, biology, and engineering, transforming the possibilities for treating organ failure and sensory impairments. These synthetic solutions are specifically designed to replicate or augment the function of natural organs and body parts, providing an invaluable alternative for individuals affected by severe medical conditions. Artificial organs, such as synthetic hearts, lungs, and kidneys, aim to assume the roles of their biological counterparts, offering a viable option to those awaiting organ transplants. Concurrently, bionic implants, including cochlear and retinal implants, endeavor to restore sensory capabilities by integrating advanced technologies within the human body. The evolution of these medical marvels has been fueled by relentless advancements in bioengineering, nanotechnology, robotics, and artificial intelligence, expanding the horizons of therapeutic interventions.

Japan Artificial Organs and Bionic Implants Market Trends:

The primary drivers of the Japan artificial organs and bionic implants market are the escalating number of transplants and the growing population awaiting donors. Furthermore, numerous advancements in healthcare infrastructures and the presence of sophisticated artificial support systems are propelling to elevate the demand for these solutions. Apart from this, progress in 3D bioprinting technology has been pivotal in organ transplantation, serving as a technique for creating artificial organs. Additionally, the inflating popularity of 3D bioprinting is generally, due to its role in reducing the chances of organ rejection. Besides this, artificial intelligence is on the brink of reshaping the international paradigms for synthetic devices, which is acting as another significant growth-inducing factor. At present, key market players are centering their efforts on a tool designed for personalized evaluation of organ and donor compatibility. This instrument is anticipated to be instrumental in facilitating informed decisions regarding organ extraction and will also assist patients in determining whether to proceed with donor organs or hold out for more suitable alternatives. Moreover, supportive reimbursement frameworks and expedited FDA approvals for implants are expected to fuel the Japan artificial organs and bionic implants market in the coming years.

Japan Artificial Organs and Bionic Implants Market Segmentation:

Product Type Insights:

  • Artificial Organ
    • Artificial Heart
    • Artificial Kidney
    • Artificial Lungs
    • Cochlear Implants
    • Others
  • Bionics
    • Vision Bionics
    • Cardiac Bionics
    • Orthopedic Bionic
    • Others

Technology Insights:

  • Mechanical Bionics
  • Electronic Bionics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan artificial organs and bionic implants market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan artificial organs and bionic implants market?
  • What is the breakup of the Japan artificial organs and bionic implants market on the basis of product type?
  • What is the breakup of the Japan artificial organs and bionic implants market on the basis of technology?
  • What are the various stages in the value chain of the Japan artificial organs and bionic implants market?
  • What are the key driving factors and challenges in the Japan artificial organs and bionic implants?
  • What is the structure of the Japan artificial organs and bionic implants market and who are the key players?
  • What is the degree of competition in the Japan artificial organs and bionic implants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Artificial Organs and Bionic Implants Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Artificial Organs and Bionic Implants Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Artificial Organs and Bionic Implants Market - Breakup by Product Type

  • 6.1 Artificial Organ
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Artificial Heart
      • 6.1.3.2 Artificial Kidney
      • 6.1.3.3 Artificial Lungs
      • 6.1.3.4 Cochlear Implants
      • 6.1.3.5 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Bionics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Vision Bionics
      • 6.2.3.2 Cardiac Bionics
      • 6.2.3.3 Orthopedic Bionic
      • 6.2.3.4 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Artificial Organs and Bionic Implants Market - Breakup by Technology

  • 7.1 Mechanical Bionics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Electronic Bionics
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Artificial Organs and Bionic Implants Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Artificial Organs and Bionic Implants Market - Industry Analysis

  • 10.1 Drivers, Restraints and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix